WeBuy Global Ltd. (NASDAQ:WBUY – Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totaling 108,785 shares, a decline of 51.0% from the April 30th total of 222,184 shares. Approximately 2.0% of the shares of the stock are short sold. Based on an average daily volume of 35,242 shares, the days-to-cover ratio is presently 3.1 days.
Analyst Ratings Changes
Separately, Weiss Ratings raised WeBuy Global from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 15th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.
Read Our Latest Research Report on WBUY
WeBuy Global Stock Performance
WeBuy Global (NASDAQ:WBUY – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.20 by ($0.20). The firm had revenue of $4.86 million during the quarter, compared to the consensus estimate of $67.20 million.
WeBuy Global Company Profile
WeBuy Global Holdings Ltd (NASDAQ: WBUY) is a Cayman Islands–registered e-commerce company that operates a vertically integrated platform for sourcing, marketing and distributing consumer goods to both international and domestic markets. The company is primarily engaged in two business segments: cross-border e-commerce, which focuses on selling factory-direct and overstock products to overseas consumers, and domestic distribution and wholesale, which provides supply-chain and bulk-sales services to retailers and third-party platforms within China.
In its cross-border e-commerce segment, WeBuy Global leverages proprietary online channels and partnerships with major global marketplaces to offer categories such as home and kitchen appliances, furniture and home décor, personal care items and small electronics.
Recommended Stories
- Five stocks we like better than WeBuy Global
- Kohl’s Stock Soars After Better-Than-Feared Quarter
- Credo Technologies Paved a Path to a $300 Price Point
- Eli Lilly Wins Back CVS Health, Reverting Novo’s Advantage
- How the Latest Federal Contract Boosts D-Wave’s Prospects
Receive News & Ratings for WeBuy Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WeBuy Global and related companies with MarketBeat.com's FREE daily email newsletter.
